In this episode, we explore how AI is reshaping software development, hardware, and even drug discovery. First, we look at GitHub’s bold move to open its Copilot coding assistant to multiple AI models, letting developers choose between Anthropic’s Claude, Google’s Gemini, and OpenAI’s tools. Then, we dive into OpenAI’s ambitious hardware shift as they partner with Broadcom and TSMC to create custom AI chips, aiming to reduce dependence on Nvidia and cut compute costs. Finally, we discuss Enchant, a breakthrough AI from Iambic Therapeutics, designed to predict drug success early in development — potentially transforming biotech timelines.